Rhumbline Advisers Galapagos Nv Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Galapagos Nv stock. As of the latest transaction made, Rhumbline Advisers holds 4,823 shares of GLPG stock, worth $114,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,823
Previous 4,578
5.35%
Holding current value
$114,932
Previous $113,000
22.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GLPG
# of Institutions
84Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$37.4 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$33.6 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$24.5 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$19.1 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$17.2 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.57B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...